Literature DB >> 8941581

Sera from patients with anti-GBM nephritis including goodpasture syndrome show heterogenous reactivity to recombinant NC1 domain of type IV collagen alpha chains.

P Dehan1, M Weber, X Zhang, S T Reeders, J M Foidart, K Tryggvason.   

Abstract

BACKGROUND: Goodpasture (GP) syndrome is defined by the clinical association of pulmonary haemorrhage with rapidly progressive glomerulonephritis. The disease is caused by pathogenic autoantibodies directed against type IV collagen, which is a major structural component of glomerular basement membranes (GBM).
METHODS: The non-collagenous domains (NC1) of all six human type IV collagen alpha chains was produced in E. coli as recombinant fusion proteins with glutathione-S transferase. Sera from 10 patients with different types of anti-GBM nephritis, including GP syndrome, were tested for reactivity with the six proteins using immunoblotting of denatured and reduced proteins and ELISA without reduction.
RESULTS: All 10 sera reacted with the alpha 3 (IV) collagen chain by immunoblotting and ELISA. One serum also recognized the alpha 2(IV), alpha 4(IV), alpha 5(IV) and alpha 6(IV) chains by immunoblotting. ELISA measurements revealed reactivity of several other sera with alpha 2(IV), alpha 4(IV) or alpha 6(IV) but not with alpha 5(IV) collagen chains. No reactivity was observed with the alpha 1(IV) chain.
CONCLUSION: Autoantibodies in anti-GBM nephritis may not be directed only against the alpha 3(IV) collagen chain and they frequently recognize conformational epitopes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8941581     DOI: 10.1093/oxfordjournals.ndt.a027139

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  6 in total

Review 1.  Goodpasture's disease: molecular architecture of the autoantigen provides clues to etiology and pathogenesis.

Authors:  Vadim Pedchenko; Roberto Vanacore; Billy Hudson
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-05       Impact factor: 2.894

2.  Down-Regulation of MT1-MMP expression by the alpha3 chain of type IV collagen inhibits bronchial tumor cell line invasion.

Authors:  C Martinella-Catusse; M Polette; A Noel; C Gilles; P Dehan; C Munaut; A Colige; L Volders; J C Monboisse; J M Foidart; P Birembaut
Journal:  Lab Invest       Date:  2001-02       Impact factor: 5.662

Review 3.  Advances in human antiglomerular basement membrane disease.

Authors:  Zhao Cui; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2011-07-19       Impact factor: 28.314

4.  Recombinant alpha-chains of type IV collagen demonstrate that the amino terminal of the Goodpasture autoantigen is crucial for antibody recognition.

Authors:  J J Ryan; P J Mason; C D Pusey; N Turner
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

5.  Antibodies to α5 chain of collagen IV are pathogenic in Goodpasture's disease.

Authors:  Zhao Cui; Ming-Hui Zhao; Xiao-Yu Jia; Miao Wang; Shui-Yi Hu; Su-Xia Wang; Feng Yu; Kyle L Brown; Billy G Hudson; Vadim Pedchenko
Journal:  J Autoimmun       Date:  2016-04-23       Impact factor: 7.094

6.  The prevalence and immunological features of anti-glomerular basement membrane antibody in patients with HIV.

Authors:  Wen-Jing Wang; Xiao-Yu Jia; Zhao Cui; Yan Chen; Wei Wang; Jin-Li Lou; Ming-Hui Zhao; Sun Ying
Journal:  BMC Nephrol       Date:  2020-10-08       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.